Ureter Small Cell Carcinoma Recruiting Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0113277 (Ureter Small Cell Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03582475Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateTreatment